Celldex Therapeutics, Inc. (CLDX)
23.44
-1.16
(-4.72%)
USD |
NASDAQ |
Feb 12, 16:00
23.41
-0.03
(-0.13%)
After-Hours: 19:13
Celldex Therapeutics Total Assets (Quarterly) : 648.44M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Atossa Therapeutics, Inc. | 58.01M |
| Abeona Therapeutics, Inc. | 231.10M |
| Cell Source, Inc. | 0.2865M |
| Kiora Pharmaceuticals, Inc. | 29.86M |
| Intellia Therapeutics, Inc. | 925.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 50.08M |
| Shareholders Equity (Quarterly) | 598.36M |
| Debt to Equity Ratio | 0.0044 |
| Current Ratio | 13.01 |
| Net Debt Paydown Yield | -0.00% |